To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC only game in European biotech
Over nine out of every ten euros invested in European biotechnology companies in 2002 came from venture capitalists, often injecting more capital into later stage portfolio companies.
